Estudio prospectivo, randomizado para comparar paratiroidectomía subtotal versus cinacalcet en el tratamiento del hiperparatiroidismo secundario persistente post trasplante renal. - 01PTHi

Active, not recruiting

• Conditions: Hiperparatiroidismo secundario post trasplante renal; MedDRA version: 9.1Level: LLTClassification code 10020708Term: Hyperparathyroidism secondary

• Registration Number: EUCTR2008-007017-76-ES
• Lead Sponsor: Josep M Cruzado

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2008-11-26
• Last Update Posted: 3 November 2014

Recruitment & Eligibility

• Status: Not Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1.Functionning renal allograft, estimated GFR = 30 ml/min
2.More than 6 m after transplantation
3.PTHi =15 pmol/L
4.Calcemia =2.7 mmol/L with phosphatemia =1.2 mmol/L
5.MIBI
6.Written informed consent

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

1.Surgical contraindication

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified